SEC
RXST icon

Seven Eight Capital’s RxSight RXST Stock Holding History

Seven Eight Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,892
Closed -$1.58M – 518
2024
Q3 		$1.58M Buy
31,892
+6,293
+25% +$322K 0.14% 248
2024
Q2 		$1.54M Sell
25,599
-4,567
-15% -$261K 0.16% 213
2024
Q1 		$1.56M Buy
30,166
+3,248
+12% +$159K 0.16% 196
2023
Q4 		$1.09M Buy
+26,918
New +$790K 0.13% 233

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Seven Eight Capital's RXST Position: Q4 2024 in Review

Seven Eight Capital sold out of RxSight (RXST) in Q4 2024, closing a stake of 31,892 shares — an estimated $1.58M sold.

Seven Eight Capital first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $1.58M in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Seven Eight Capital reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 31,892 RxSight shares in Q4 2024, an estimated $1.58M.
  • Seven Eight Capital first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
  • Seven Eight Capital's RxSight position peaked at $1.58M in Q3 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.